CLASS III Drug recall · Reported 21 Feb 2018 · FDA Enforcement Report

Norco (Hydrocodone Bitartrate and Acetaminophen) Tablets recalled

Allergan is recalling Norco (Hydrocodone Bitartrate and Acetaminophen) Tablets, USP, 10 mg/325 mg, distributed nationwide in the US. The recall was initiated on 2 Feb 2018 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 544821A, Exp 07/19
Quantity recalled8 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0413-2018
FDA event ID
79080
Recalling firm
Allergan, Madison, NJ
Classification
Class III
Status
Terminated
Recall initiated
2 Feb 2018
FDA classified
9 Feb 2018
Reported
21 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

2 Feb 2018Recall initiated by company
9 Feb 2018Classified by FDA+7 days
21 Feb 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Not Elsewhere Classified: does not have the required "CII" controlled drug classification indication on the primary label.

Product as listed by the FDA

NORCO (Hydrocodone Bitartrate and Acetaminophen) Tablets, USP, 10 mg/325 mg, 100-count bottles, Rx Only, Distributed by: Allergan USA, Inc., Irvine, CA 92612, NDC 0023-6022-01.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Not Elsewhere Classified: does not have the required "CII" controlled drug classification indication on the primary label.

Which lots are affected?

Lot # 544821A, Exp 07/19

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Allergan

All 29